Pharma & Healthcare

Global CGRP Monoclonal Antibodies Market Research Report 2026

This report delivers a comprehensive overview of the global CGRP Monoclonal Antibodies market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CGRP Monoclonal Antibodies. The CGRP Monoclonal Antibodies market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global CGRP Monoclonal Antibodies market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist CGRP Monoclonal Antibodies manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Lundbeck
Alder Therapeutics
Teva
Pfizer Inc.
Lilly Inc.
Daiichi Sankyo Co., Ltd.
Amgen Inc.
Novartis International AG
Segment by Type
Eptinezumab
Fremanezumab
Galcanezumab
Erenumab
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for CGRP Monoclonal Antibodies companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGRP Monoclonal Antibodies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Eptinezumab
1.2.3 Fremanezumab
1.2.4 Galcanezumab
1.2.5 Erenumab
1.3 Market by Application
1.3.1 Global CGRP Monoclonal Antibodies Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGRP Monoclonal Antibodies Market Perspective (2021–2032)
2.2 Global CGRP Monoclonal Antibodies Growth Trends by Region
2.2.1 Global CGRP Monoclonal Antibodies Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 CGRP Monoclonal Antibodies Historic Market Size by Region (2021–2026)
2.2.3 CGRP Monoclonal Antibodies Forecasted Market Size by Region (2027–2032)
2.3 CGRP Monoclonal Antibodies Market Dynamics
2.3.1 CGRP Monoclonal Antibodies Industry Trends
2.3.2 CGRP Monoclonal Antibodies Market Drivers
2.3.3 CGRP Monoclonal Antibodies Market Challenges
2.3.4 CGRP Monoclonal Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CGRP Monoclonal Antibodies Players by Revenue
3.1.1 Global Top CGRP Monoclonal Antibodies Players by Revenue (2021–2026)
3.1.2 Global CGRP Monoclonal Antibodies Revenue Market Share by Players (2021–2026)
3.2 Global Top CGRP Monoclonal Antibodies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by CGRP Monoclonal Antibodies Revenue
3.4 Global CGRP Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global CGRP Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGRP Monoclonal Antibodies Revenue in 2025
3.5 Global Key Players of CGRP Monoclonal Antibodies Head Offices and Areas Served
3.6 Global Key Players of CGRP Monoclonal Antibodies, Products and Applications
3.7 Global Key Players of CGRP Monoclonal Antibodies, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 CGRP Monoclonal Antibodies Breakdown Data by Type
4.1 Global CGRP Monoclonal Antibodies Historic Market Size by Type (2021–2026)
4.2 Global CGRP Monoclonal Antibodies Forecasted Market Size by Type (2027–2032)
5 CGRP Monoclonal Antibodies Breakdown Data by Application
5.1 Global CGRP Monoclonal Antibodies Historic Market Size by Application (2021–2026)
5.2 Global CGRP Monoclonal Antibodies Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America CGRP Monoclonal Antibodies Market Size (2021–2032)
6.2 North America CGRP Monoclonal Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America CGRP Monoclonal Antibodies Market Size by Country (2021–2026)
6.4 North America CGRP Monoclonal Antibodies Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CGRP Monoclonal Antibodies Market Size (2021–2032)
7.2 Europe CGRP Monoclonal Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe CGRP Monoclonal Antibodies Market Size by Country (2021–2026)
7.4 Europe CGRP Monoclonal Antibodies Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CGRP Monoclonal Antibodies Market Size (2021–2032)
8.2 Asia-Pacific CGRP Monoclonal Antibodies Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific CGRP Monoclonal Antibodies Market Size by Region (2021–2026)
8.4 Asia-Pacific CGRP Monoclonal Antibodies Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CGRP Monoclonal Antibodies Market Size (2021–2032)
9.2 Latin America CGRP Monoclonal Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America CGRP Monoclonal Antibodies Market Size by Country (2021–2026)
9.4 Latin America CGRP Monoclonal Antibodies Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CGRP Monoclonal Antibodies Market Size (2021–2032)
10.2 Middle East & Africa CGRP Monoclonal Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2021–2026)
10.4 Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lundbeck
11.1.1 Lundbeck Company Details
11.1.2 Lundbeck Business Overview
11.1.3 Lundbeck CGRP Monoclonal Antibodies Introduction
11.1.4 Lundbeck Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.1.5 Lundbeck Recent Development
11.2 Alder Therapeutics
11.2.1 Alder Therapeutics Company Details
11.2.2 Alder Therapeutics Business Overview
11.2.3 Alder Therapeutics CGRP Monoclonal Antibodies Introduction
11.2.4 Alder Therapeutics Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.2.5 Alder Therapeutics Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva CGRP Monoclonal Antibodies Introduction
11.3.4 Teva Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.3.5 Teva Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. CGRP Monoclonal Antibodies Introduction
11.4.4 Pfizer Inc. Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.4.5 Pfizer Inc. Recent Development
11.5 Lilly Inc.
11.5.1 Lilly Inc. Company Details
11.5.2 Lilly Inc. Business Overview
11.5.3 Lilly Inc. CGRP Monoclonal Antibodies Introduction
11.5.4 Lilly Inc. Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.5.5 Lilly Inc. Recent Development
11.6 Daiichi Sankyo Co., Ltd.
11.6.1 Daiichi Sankyo Co., Ltd. Company Details
11.6.2 Daiichi Sankyo Co., Ltd. Business Overview
11.6.3 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Introduction
11.6.4 Daiichi Sankyo Co., Ltd. Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.6.5 Daiichi Sankyo Co., Ltd. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. CGRP Monoclonal Antibodies Introduction
11.7.4 Amgen Inc. Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis International AG
11.8.1 Novartis International AG Company Details
11.8.2 Novartis International AG Business Overview
11.8.3 Novartis International AG CGRP Monoclonal Antibodies Introduction
11.8.4 Novartis International AG Revenue in CGRP Monoclonal Antibodies Business (2021–2026)
11.8.5 Novartis International AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CGRP Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Eptinezumab
Table 3. Key Players of Fremanezumab
Table 4. Key Players of Galcanezumab
Table 5. Key Players of Erenumab
Table 6. Global CGRP Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global CGRP Monoclonal Antibodies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global CGRP Monoclonal Antibodies Market Size by Region (US$ Million), 2021–2026
Table 9. Global CGRP Monoclonal Antibodies Market Share by Region (2021–2026)
Table 10. Global CGRP Monoclonal Antibodies Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global CGRP Monoclonal Antibodies Market Share by Region (2027–2032)
Table 12. CGRP Monoclonal Antibodies Market Trends
Table 13. CGRP Monoclonal Antibodies Market Drivers
Table 14. CGRP Monoclonal Antibodies Market Challenges
Table 15. CGRP Monoclonal Antibodies Market Restraints
Table 16. Global CGRP Monoclonal Antibodies Revenue by Players (US$ Million), 2021–2026
Table 17. Global CGRP Monoclonal Antibodies Market Share by Players (2021–2026)
Table 18. Global Top CGRP Monoclonal Antibodies Players by Tier (Tier 1, Tier 2, and Tier 3), based on CGRP Monoclonal Antibodies Revenue, 2025
Table 19. Ranking of Global Top CGRP Monoclonal Antibodies Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by CGRP Monoclonal Antibodies Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of CGRP Monoclonal Antibodies, Headquarters and Area Served
Table 22. Global Key Players of CGRP Monoclonal Antibodies, Products and Applications
Table 23. Global Key Players of CGRP Monoclonal Antibodies, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global CGRP Monoclonal Antibodies Market Size by Type (US$ Million), 2021–2026
Table 26. Global CGRP Monoclonal Antibodies Revenue Market Share by Type (2021–2026)
Table 27. Global CGRP Monoclonal Antibodies Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global CGRP Monoclonal Antibodies Revenue Market Share by Type (2027–2032)
Table 29. Global CGRP Monoclonal Antibodies Market Size by Application (US$ Million), 2021–2026
Table 30. Global CGRP Monoclonal Antibodies Revenue Market Share by Application (2021–2026)
Table 31. Global CGRP Monoclonal Antibodies Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global CGRP Monoclonal Antibodies Revenue Market Share by Application (2027–2032)
Table 33. North America CGRP Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2021–2026
Table 35. North America CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2027–2032
Table 36. Europe CGRP Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2021–2026
Table 38. Europe CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific CGRP Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific CGRP Monoclonal Antibodies Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific CGRP Monoclonal Antibodies Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America CGRP Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa CGRP Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa CGRP Monoclonal Antibodies Market Size by Country (US$ Million), 2027–2032
Table 48. Lundbeck Company Details
Table 49. Lundbeck Business Overview
Table 50. Lundbeck CGRP Monoclonal Antibodies Product
Table 51. Lundbeck Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 52. Lundbeck Recent Development
Table 53. Alder Therapeutics Company Details
Table 54. Alder Therapeutics Business Overview
Table 55. Alder Therapeutics CGRP Monoclonal Antibodies Product
Table 56. Alder Therapeutics Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 57. Alder Therapeutics Recent Development
Table 58. Teva Company Details
Table 59. Teva Business Overview
Table 60. Teva CGRP Monoclonal Antibodies Product
Table 61. Teva Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 62. Teva Recent Development
Table 63. Pfizer Inc. Company Details
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. CGRP Monoclonal Antibodies Product
Table 66. Pfizer Inc. Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 67. Pfizer Inc. Recent Development
Table 68. Lilly Inc. Company Details
Table 69. Lilly Inc. Business Overview
Table 70. Lilly Inc. CGRP Monoclonal Antibodies Product
Table 71. Lilly Inc. Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 72. Lilly Inc. Recent Development
Table 73. Daiichi Sankyo Co., Ltd. Company Details
Table 74. Daiichi Sankyo Co., Ltd. Business Overview
Table 75. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product
Table 76. Daiichi Sankyo Co., Ltd. Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 77. Daiichi Sankyo Co., Ltd. Recent Development
Table 78. Amgen Inc. Company Details
Table 79. Amgen Inc. Business Overview
Table 80. Amgen Inc. CGRP Monoclonal Antibodies Product
Table 81. Amgen Inc. Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 82. Amgen Inc. Recent Development
Table 83. Novartis International AG Company Details
Table 84. Novartis International AG Business Overview
Table 85. Novartis International AG CGRP Monoclonal Antibodies Product
Table 86. Novartis International AG Revenue in CGRP Monoclonal Antibodies Business (US$ Million), 2021–2026
Table 87. Novartis International AG Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. CGRP Monoclonal Antibodies Picture
Figure 2. Global CGRP Monoclonal Antibodies Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global CGRP Monoclonal Antibodies Market Share by Type: 2025 vs 2032
Figure 4. Eptinezumab Features
Figure 5. Fremanezumab Features
Figure 6. Galcanezumab Features
Figure 7. Erenumab Features
Figure 8. Global CGRP Monoclonal Antibodies Market Size by Application (US$ Million), 2021–2032
Figure 9. Global CGRP Monoclonal Antibodies Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Specialty Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. CGRP Monoclonal Antibodies Report Years Considered
Figure 14. Global CGRP Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global CGRP Monoclonal Antibodies Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global CGRP Monoclonal Antibodies Market Share by Region: 2025 vs 2032
Figure 17. Global CGRP Monoclonal Antibodies Market Share by Players in 2025
Figure 18. Global CGRP Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by CGRP Monoclonal Antibodies Revenue in 2025
Figure 20. North America CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America CGRP Monoclonal Antibodies Market Share by Country (2021–2032)
Figure 22. United States CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe CGRP Monoclonal Antibodies Market Share by Country (2021–2032)
Figure 26. Germany CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific CGRP Monoclonal Antibodies Market Share by Region (2021–2032)
Figure 34. China CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America CGRP Monoclonal Antibodies Market Share by Country (2021–2032)
Figure 42. Mexico CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa CGRP Monoclonal Antibodies Market Share by Country (2021–2032)
Figure 46. Israel CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE CGRP Monoclonal Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Lundbeck Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 50. Alder Therapeutics Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 51. Teva Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 52. Pfizer Inc. Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 53. Lilly Inc. Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 54. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 55. Amgen Inc. Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 56. Novartis International AG Revenue Growth Rate in CGRP Monoclonal Antibodies Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies